In a novel application of two-photon scanning¯uores-cence microscopy, three-dimensional spatial distributions of the hydrophilic and hydrophobic¯uorescent probes, sulforhodamine B and rhodamine B hexyl ester, in excised full-thickness human cadaver skin were visualized and quanti®ed. Both sulforhodamine B and rhodamine B hexyl ester were observed to lie primarily in the lipid multilamellae region surrounding the corneocytes within the stratum corneum. From the two-photon scanning¯uorescence microscopy scans, the changes in the concentration gradient and the vehicle to skin partition coef®cient of each probe induced by the oleic acid enhancer action were calculated relative to the control sample (not exposed to oleic acid), and subsequently applied to theoretically derived mathematical expressions of transdermal transport to quantitatively characterize the oleic acid-induced relative changes in the skin diffusion coef®cient and the skin barrier diffusion length of the permeant. For the hydrophobic probe rhodamine B hexyl ester, the permeability enhancement was primarily driven by an increase in the vehicle to skin partition coef®cient, leading to an increase in the steepness of the concentration gradient across the skin. The primary oleic acid-induced changes in the transport properties of the hydrophilic probe sulforhodamine B included increases in the vehicle to skin partition coef®cient and the skin diffusion coef®cient. These ®ndings utilizing the two-photon scanning¯uorescence microscopy methodology and data analysis described here demonstrate that, in addition to providing threedimensional images that clearly delineate probe distributions in the direction of increasing skin depth, the subsequent quanti®cation of these images provides additional important insight into the mechanistic changes in transdermal transport underlying the visualized changes in probe distributions across the skin. Key words: chemical enhancement mechanism/excised human skin/¯uorescent probe distribution/oleic acid/twophoton scanning¯uorescence microscopy.
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Experimental techniques utilized in mechanistic studies of chemically induced transdermal drug permeability enhancement have included Fourier transform infrared spectroscopy, differential scanning calorimetry, and nuclear magnetic resonance spectroscopy (Schaefer and Redelmeier, 1996) . For oleic acid, a well-known chemical enhancer, these techniques have been helpful in identifying the mode of chemical enhancer action as a¯uidization of the lipid multilamellae which form the continuous phase of the SC (Francoeur et al, 1990; Schaefer and Redelmeier, 1996) . The correlation found between increased transdermal drug¯ux and increased lipid¯uidity strongly suggests that oleic acid alters the packing structure of the SC lipids to increase lipid¯uidity and reduce skin resistance to drug transport (Golden et al, 1987) . Furthermore, the mechanism of oleic acid chemical enhancer action has been associated with the formation of phase-separated oleic acid domains in the SC multilamellar lipids (Ongpipattanakul et al, 1991) . Whereas the above-mentioned studies (Golden et al, 1987; Francoeur et al, 1990; Schaefer and Redelmeier, 1996) have clearly elucidated the role of oleic acid in altering SC lipid ordering, the changes in the microscale transport properties of the permeant, including the vehicle to skin partition coef®cient, the skin diffusion coef®cient, and the skin barrier diffusion length, that underlie the experimentally measured increases in the transdermal permeability of the permeant, remain to be clari®ed.
Laser scanning confocal¯uorescence microscopy has been utilized to visualize hydrophobic and hydrophilic¯uorescent probe spatial distributions across the skin (Turner and Guy, 1997; Kuijk-Meuwissen et al, 1998) ; however, three-dimensional imaging using this technique is limited by increased light scattering within the medium. In laser scanning confocal uorescence microscopy, the¯uorescent probe penetration is, therefore, often imaged by sectioning skin samples perpendicular to the skin surface such that the ®eld of view captures thē uorescent probe distribution from the SC to the dermis all in one plane. Because skin sample sections often undergo exposure to chemicals and mechanical forces in the curing, setting, and sectioning stages of the sample preparation procedure, the presence of artifacts in the ®nal sample remains a potential risk.
As a noninvasive method for directly visualizing the skin structural features, TPM has been successfully used to image in vivo human skin (Masters et al, 1998) . More recently, TPM has been utilized to visualize in vitro permeant spatial distributions across human cadaver skin. 1±3 In TPM, tight focusing in a laser scanning microscope, combined with a femtosecond pulsed laser, enables a dye molecule to simultaneously absorb two longwavelength photons to reach its excited state (Denk et al, 1990) . The quadratic dependence of the excitation probability results in greater three-dimensional depth discrimination. The long-wavelength photon source used in TPM allows deeper light penetration into media with a high degree of scattering (Denk et al, 1995; Diaspro, 1999; Soeller and Cannell, 1999) , thus making it well suited for imaging the skin (Masters et al, 1998) .
Other attributes of TPM include its use of a large area signal detector that maximizes the photon collection ef®ciency, and the localization of the excitation volume to the focal region, which results in minimized photodamage and photobleaching (Masters et al, 1997; Periasamy et al, 1999) .
Despite the application of TPM to visualize probe distributions in the skin (Grewal et al 2000) , to date, TPM scans of uorescent probe distributions in the skin have not been rigorously analyzed to characterize quantitatively the changes in the transdermal transport properties resulting from chemical enhancer action. The structural complexity of the SC (described below) poses signi®cant challenges to the quantitative analysis of average probe transport properties in the skin. This analysis relies on an accurate assessment of the¯uorescent probe concentration distributions throughout the skin depth. To demonstrate the quantitative analysis methodology described below in detail, the SC was treated as a membrane in which the corneocytes and lipid multilamellae are collectively considered in the quanti®cation of the¯uorescent probe distributions in the SC. This approach, in which the corneocytes were not excluded from the analysis of transdermal permeant transport, has been commonly employed by other researchers (Mak et al, 1990; Naik et al, 1995; Pirot et al, 1997) . Hence, the ensuing description of the TPM methodology utilized in the transdermal transport studies and the quanti®cation of the changes detected in the microscale transport properties relative to the control case, introduce, for the ®rst time, the novel application of TPM to this in vitro model skin system to elucidate the mechanism of chemical enhancer action.
In the studies reported here, three-dimensional images of uorescent probe spatial distributions across full-thickness human cadaver skin were constructed utilizing TPM data. Oleic acidinduced changes in the probe concentration gradient, as well as in the microtransport properties of the probe, including the skin diffusion coef®cient, the skin barrier diffusion length, and the vehicle to skin partition coef®cient, all of which in¯uence the experimentally measured permeability of the probe across the skin, were quanti®ed relative to the control case (without oleic acid) based on a theoretical analysis of these three-dimensional images to shed light on the mechanisms of chemically enhanced transdermal transport.
The SCÐthe outermost 10±20 mm layer of the skinÐis the primary barrier to transdermal drug transport (Bommannan et al, 1990) , and consists of corneocytes embedded in a continuous phase of lipid multilamellae (LB), as depicted in the schematic illustration of the brick and mortar model of the SC including the viable epidermis (VE) shown in Fig 1. The two-photon microscopy images discussed below will highlight permeant diffusion across the SC and a portion of the underlying VE.
The steady-state¯ux, J, of a permeant across the SC membrane in the absence of convective solvent¯ow is Figure 1 . Schematic illustration of the brick and mortar model of the SC, including the VE. The corneocytes (C) and keratinocytes (K) are represented by the brick-like structures in the continuous phase of the lipid bilayer lamellae (LB) that comprise the intercellular space. In the SCÐthe ®rst 10±20 mm of the skinÐcorneocytes have estimated dimensions of 40 mm in diameter and 0.8 mm in thickness, whereas the intercellular space thickness is estimated to be 75 nm. The keratinocytes (10 mm in diameter) in the VE undergo compression (7±0.8 mm) as they differentiate and migrate to the SC to form the corneocytes. commonly described using the one dimensional Fick's First Law of diffusion, namely,
where D is the effective permeant diffusion coef®cient in the membrane, and dC/dz is the concentration gradient in the zdirection, or the direction of increasing SC depth (Peck et al, 1996; Pugh et al, 1998) . From Eqn 1, changes in the permeant¯ux are driven by changes in two microtransport properties, D and dC/dz. Additional transport properties that contribute to the experimentally measured permeant skin permeability include the permeant vehicle to skin partition coef®cient, K, and the skin barrier diffusion length, l. As discussed later, the skin barrier diffusion length, l, represents the thickness of the skin region over which the greatest barrier to permeant transdermal transport is exhibited. In discussions of percutaneous absorption, in which a constant donor solution concentration and a zero concentration receiver solution were assumed, the mathematical models derived for transdermal transport yield expressions for diffusion in one dimension (Scheuplein, 1967; Pirot et al, 1997) . With z/R < < 1, where z and R are the skin depth and the skin diffusion area radius, respectively, and with the donor solution-imposed concentration gradient in the z-direction, the mathematical expression for multidimensional transport can be simpli®ed to one dimension (Deen, 1998) . Currently, experimental methods are not available to determine directly the permeant diffusion coef®cient in the skin in vitro, and SC models have relied on measurements of diffusion coef®cients in liposomes of various lipid compositions (Johnson et al, 1996a) . In this study, we will focus on the oleic acid enhancer induced changes in the relevant transport properties discussed above, relative to the experimental control (without the enhancer), for each probe examined. The quanti®cation of the relative change for each transport property under investigation is reported as an enhancement factor, E, which is the ratio of the value of the transport property with and without the chemical enhancer. From TPM data, the relative change in the vehicle to skin partition coef®cient for each probe can be directly determined. Consequently, the relative change in the probe diffusion coef®cient due to oleic acid enhancer action can be calculated using the following expression relating the probe¯ux, J, to its permeability, P (Schaefer and Redelmeier, 1996) :
where DC is the difference in the probe concentration between the donor and the receiver compartments of the side-by-side diffusion cell used to measure P. For a given value of DC, the permeability enhancement, E P , which is the ratio of the permeant permeability in the presence of the chemical enhancer and that of the control (without the chemical enhancer), can be obtained by using Eqn 2 in Eqn 1, and then taking the ratio of the resulting expression for the chemical enhancer (E) and the control (C) samples. Speci®cally,
where the ®rst derivative, or the slope, of the linear permeant concentration pro®le (discussed later) established in the SC at steady-state conditions is a constant quantity. Note that E P = P E / P C can be calculated from the ratio of the measured transdermal permeabilities of each permeant at the two conditions (E and C) examined. Recall that, in general, the permeant permeability can be obtained as follows:
where (dN/dt) r is the change in the amount of permeant over time in the receiver compartment, and A is the area of the skin exposed to the donor solution. Moreover, for the steady-state transport of a permeant through biologic membranes, the permeant partition coef®cient between the donor solution and the skin, K, and the skin barrier diffusion length, l, also play signi®cant parts in determining the magnitude of the permeability coef®cient, P. Speci®cally (Schaefer and Redelmeier, 1996) ,
Using Eqn 5, one can express the permeability enhancement, E P , in the following alternate useful form:
Substituting Eqn 3 in Eqn 6, the skin barrier diffusion length enhancement, E l , can be expressed in the following useful form:
where
is the concentration-gradient enhancement. Equation 10 allows the calculation of the skin barrier diffusion length enhancement, E l , utilizing quantities that are readily available through TPM experi-ments. Indeed, as shown below, both the concentration-gradient enhancement, E g , and the partition-coef®cient enhancement, E K , can be extracted solely from the data obtained from the TPM three-dimensional scans of the¯uorescent probe spatial distributions to determine the skin barrier diffusion length enhancement, E l , which describes the relative change in the thickness of the permeant diffusion barrier in the z-direction resulting from the chemical enhancer action.
MATERIALS AND METHODS
Preparation of skin sample for imaging Full-thickness human cadaver skin from the abdominal area (National Disease Research Interchange, Philadelphia, PA), acquired 10±20 h post mortem, was stored at ± 80°C and utilized within 3±6 wk. Upon use, the skin was thawed at room temperature (25°C), and the fat from the dermal side was removed. Skin samples of 2.25 cm 2 were mounted in side-by-side diffusion cells (9 mm diameter, PermeGear, Riegelsville, PA), and then immersed in phosphate-buffered saline (PBS; 0.01 M phosphate buffer, 0.0027 M KCl and 0.137 NaCl, pH = 7.4; Sigma, St Louis, MO) for the measurement of skin conductivities.
Skin conductivity measurements Skin conductivities for all the skin samples examined were measured as an indicator of the skin barrier integrity (Kontturi et al, 1993; Peck et al, 1994; Kalia and Guy, 1995) . Ag±AgCl electrodes (E242, In Vivo Metric, Healdsburg, California) were connected to an AC signal generator (HP 33120A 15 MHz Function Arbitrary Waveform Generator, Hewlett Packard, Palo Alto, California) in series with a digital multimeter (Radio Shack, Fort Worth, TX). One electrode was placed in each compartment of the diffusion cell, ®lled with PBS, and a voltage drop of 100 mV was applied across the skin. To a 10 Hz current reading, the conductivity criterion of > 10 kW cm 2 was applied (Rossel et al, 1988) , with skin samples not meeting this criterion replaced by intact skin.
Fluorescent probe properties The two¯uorescent probes (Molecular Probes, Eugene, OR), rhodamine B hexyl ester perchlorate (RBHE) and sulforhodamine B (SRB), served as the hydrophobic and hydrophilic model drugs, respectively, and were selected based on their similarity in molecular structure, disparity in octanol±water partition coef®cient, and uorescence emission range. Figure 2 (a,b) show the chemical structures of the two¯uorescent probes, with their molecular weights (MW), uorescence absorption (ab) and emission (em) spectral peaks (ab/em), and log K O/PBS (where K O/PBS is the experimentally determined octanol±PBS partition coef®cient) listed in Table I . Whereas similar in structure, slight differences in the functional groups of RBHE and SRB result in octanol±PBS partition coef®cients that vary by three orders of magnitude. The absence of the sulfate groups (SO 3 ± ) and the addition of the hexyl ester moiety (C 6 H 13 COO) in RBHE, compared with SRB, impart a greater tendency for hydrophobic interactions. The log K O/PBS values measured for RBHE and SRB are 2.49 and ±0.45, respectively, clearly re¯ecting their roles as the hydrophobic and hydrophilic model drugs.
In addition to their physicochemical properties, these two probes were selected to minimize the effects of the skin auto¯uorescence, characterized by absorption and emission peaks of 488 nm and 515 nm, respectively (Masters et al, 1997) . Speci®cally, under the 780 nm laser excitation, the¯uorescence signals of the probes, their spectral absorption/emission peaks at 556 nm/578 nm (RBHE) and 565 nm/586 nm (SRB), have minimal overlap with that corresponding to the skin auto¯uorescence. Photon counts at each depth of the skin samples, kept in contact with the vehicles and in the absence of any¯uorescent probes, maintained an average value of 1 and lower, with SD of up to 3 photon counts. These values clearly indicate that the signal detected in the presence of the¯uorescent probe does indeed originate from thē uorescent probe alone, as the samples exposed to the¯uorescent probes yielded average photon counts that are greater by two orders of magnitude.
Donor solution preparation Donor vehicle solutions of RBHE and SRB consisting of ethanol (100%, Pharmco Products, Brook®eld, CT) and PBS (Sigma, St Louis, MO), at a 1 : 1 ratio, by volume, were prepared at concentrations of 0.5 mg per ml and 0.7 mg per ml, respectively. In preparing the solutions containing the model chemical enhancer, an additional 5% by volume of oleic acid (99%, Sigma) was added to the PBS/ethanol probe solutions. Skin samples were left in contact with well-stirred donor solutions for 48 h, until the steady-state diffusion pro®le was established.
Measurement of ®nal skin conductivities The ®nal skin conductivities of the samples were again measured as described above to determine the changes in the skin barrier function due to chemical enhancer action, as conductivity measurements have frequently served as a useful indicator of the skin barrier function, and conductivity increases have similarly been found to correlate well with permeant permeability increases (Sims et al, 1991) . Compared with the skin samples for which no changes in conductivity were measured after 48 h of contact with only PBS (the control caseÐno chemical enhancer), the skin samples treated with the oleic acid chemical enhancer indeed lowered the skin barrier function. The measured changes in skin conductivities for the samples kept in contact with the oleic acid solution are comparable with the 100±200-fold skin conductivity increases cited in the literature for skin treated with chemical enhancers (Inamori et al, 1994; Li et al, 1998) .
Skin preparation for TPM imaging Each skin sample was then removed and rinsed with PBS/ethanol (1 : 1, by volume) and blotted with a Kimwipe (Kimberly Clark, Roswell, GA) to ensure the removal of any excess¯uorescent probes present on the surface of the skin. The circular area of the skin exposed to the probes was cut out with a surgical carbon steel razor blade (VWR Scienti®c, Media, PA), and then sealed in an imaging chamber (2.5 mm Coverwell, Grace BioLaboratories, Bend, OR) with a no. 1, 22 mm square coverslip (VWR Scienti®c, Media, PA) contacting the SC side. A drop of PBS was added to the chamber to prevent the sample drying out.
Permeability measurements Control (no chemical enhancer) and chemical enhancer solutions of RBHE and SRB, prepared as described above, were radiolabeled with the equivalent tritiated probe (American Radiolabeled Chemicals, St Louis, MO) at 1 mCi per ml. Following the procedure described in the literature, the permeability measurements were performed (Johnson et al, 1996a) in triplicate using heat-stripped skin (Peck et al, 1994; (Li et al, 1998) with each of the four probevehicles, RBHE-control, RBHE-enhancer, SRB-control, and SRBenhancer, serving as the donor solution for each set of experiments. The skin conductivities were measured before and after the experiments, as described above for each sample examined. The presence of radiolabeled permeants was detected with a liquid scintillation analyzer (2200CA Tri- (a) RBHE is the hydrophobic model drug, and (b) SRB is the hydrophilic analog. The two molecules are similar in molecular weight, 627 Da and 559 Da, respectively, but are distinguished by functional groups that impart drastic differences in octanol±PBS partition coef®cients, K O/PBS . RBHE lacks the two SO 3 ± groups present in SRB, but the hexyl ester group contributes to the higher K O/PBS values measured for RBHE compared with SRB (see Table I ). The chemical structures of RBHE and SRB are illustrated in Fig 2(a,b) , respectively. MW, molecular weight of each probe; ab/em, the probe spectral absorption (ab) and emission peaks (em); log K O/PBS , measured values of the log of the probe PBS±octanol partition coef®cients (described in the Materials and Methods section).
b
Values are reported as mean T SD. Experiments were performed in triplicate. VOL. 117, NO. 1 JULY 2001 Carb, Packard Instrument Company, Downers Grove, IL), and the steady-state permeant permeabilities were calculated utilizing Eqn 4.
Determination of probe octanol±PBS partition coef®cients To obtain a calibration curve of¯uorescence intensity vs concentration, solutions of varying concentrations were prepared by diluting the stock for each¯uorescent probe. The¯uorescence intensity at each known probe concentration was then measured with a¯uorescence system (Photon Technology International, Monmouth Junction, NJ).
Two milliliters of each probe solution in PBS (» 0.05 mg per ml for RBHE and » 0.07 mg per ml for SRB) were vortexed for 30 s with 2 ml of octanol (Fisher Scienti®c, Pittsburgh, PA) in a glass vial. Experiments were performed in triplicate. The vortexed mixtures were then allowed to equilibriate for 24 h. The aqueous phases were measured with the¯uorescence system and the corresponding concentration was determined utilizing a calibration curve of probe concentration vs probē uorescence intensity. Following the measurement of the initial and ®nal probe concentrations in the aqueous phase, the quantity of probe in the octanol phase was determined by the difference between the initial and ®nal concentrations of the aqueous phase. The probe octanol±PBS partition coef®cient was calculated by taking the ratio of the ®nal probe concentration in the octanol phase and that in the PBS phase. The octanol±PBS partition coef®cients obtained here (log K O/PBS = 2.49 T 0.18 and ±0.45 T 0.0045 for RBHE and SRB, respectively; see Table I ) illustrate that for the concentrations used, SRB and RBHE act as the model hydrophilic and lipophilic molecules, respectively. Two-photon microscope The TPM instrument used in this study is shown in Fig 3, with a general description of the instrumentation located elsewhere . In these studies, a femtosecond titanium-sapphire laser (Tsunami, Spectra-Physics, Mountain View, CA) pumped by a 5 W diode-pumped, solid-state continuous wave (CW) laser (Millennia, Spectra-Physics, Mountain View, CA) provided the two-photon excitation at 780 nm. The microscope system consisted of a modi®ed inverted microscope (Axiovert 100TV, Zeiss, Thornwood, NY), a 40 Q objective lens (Zeiss F Fluar, NA 0.13), and an objective micropositioner (model p-721 PIFOC, Physik Instrumente, Germany). X±Y scans are achieved using a scanner unit (Cambridge Technology, Watertown, MA), and photon pulses from the photomultiplier are discriminated against dark noise with an ampli®er-discriminator unit (model F-100T, Advanced Research Instrument Corporation, Boulder, CO).
Data collection Per skin sample, four to six TPM scans of thē uorescence probe spatial distributions at different skin coordinates, or skin sites, were collected for each of the four treated skin samples (RBHE-control, RBHE-enhancer, SRB-control, and SRB-enhancer). The laser power (» 2 mW) was adjusted such that the¯uorescence intensity emitted by the sample remained below the detection saturation threshold. The signal detection saturation threshold, below which a linear correlation exists between the¯uorescence counts detected and the quantity of¯uorescent probe present in the sample, was determined utilizing standard probe solutions of known concentrations.
Data analysis Three-dimensional images of the TPM data were examined with Spyglass Slicer (Spyglass, Inc., Lexington, MA) data visualization software on a personal computer (Dimension XPS D300, Dell, Round Rock, TX). A corresponding average probe¯uorescence spatial distribution pro®le was calculated with an in-lab subroutine (Eric Ho, Massachusetts Institute of Technology, Cambridge, MA) for each three-dimensional scan. At each depth (z-coordinate) scanned, the subroutine averages the¯uorescence counts associated with the pixels in the 256 by 256 pixel image representing the imaged ®eld. For each site analyzed by the subroutine, a plot of the average¯uorescence count vs the corresponding skin depth generates the site-speci®c averagē uorescent probe spatial distribution pro®le (SSDP), which is the quantitative representation of the three-dimensional visualization generated with Spyglass Slicer.
Generation of¯uorescent probe intensity pro®les Per skin sample, the surface of each of the four to six sites examined, corresponding to z = 0 mm, was de®ned by the scanning depth yielding the highest average¯uorescence count. The de®nition of these surfaces normalized the different SSDP and enabled the subsequent calculation of the sample average intensity pro®le (SAIP) for each probe-vehicle combination based on the four to six sites surveyed. In calculating each SAIP, thē uorescence counts associated with each individual SSDP corresponding to a given z-coordinate were averaged. This average was then plotted vs the corresponding z-coordinate to yield the SAIP, I(z). The calculated SD from the SAIP represent the site to site variations in probe penetration within a particular skin sample.
Fluorescent probe intensity gradient calculation The intensity gradient (or the slope) corresponding to each SAIP was calculated by performing a linear regression for the data points comprising the ®rst 11 axial scans, or 8 mm, of the skin, a region encompassing the drastic decrease in probe intensity for the control cases (in the absence of chemical enhancer) to which chemical enhancer-induced changes in probe transport are compared. The error in the intensity gradient corresponding to each SAIP is expressed as the range in which a 95% con®dence level exists (see Table II ).
Because of the direct correlation between the probe¯uorescence intensity and the probe concentration established with the standard probe solutions described above, the shape of the SAIP provides a good representation of the probe concentration pro®le in the skin sample. Hence, the calculation of the concentration-gradient enhancement, E g , for each probe results from substituting the values of dI/dz, listed in Table II , for those of the corresponding probe concentration gradients, dC/dz (see Eqn 11). Based on a pointscanning approach, the instrument utilizes a tight focal spot in threedimensional imaging. Incident beams of light emitted from the diode laser pumped titanium-sapphire are de¯ected by the X±Y scanner to different angular positions, and then directed to the microscope system (area enclosed by the dotted lines). From the ®eld-aperture plane, the laser is re¯ected from the dichroic mirror to the microscope objective. The skin sample is placed below the microscope objective, with the piezo-z stage controlling the scanner in the z-direction. Signal photons from the sample are processed with the photomultiplier tube/ discriminator, and data analysis is performed with the computer. The reported intensity gradients, dI/dz, are the slopes of the SAIP corresponding to the ®rst 8 mm of each skin sample examined, and were obtained from linear regressions (see Materials and Methods). The control and enhancer vehicles are denoted by (C) and (E), respectively. The error reported for dI/dz re¯ects the range of intensity gradient values that fall within a 95% con®dence level based on the precision of the linear ®t.
Moreover, the intensity gradient of each SSDP was calculated in the same manner, and then averaged to assess the relationship between the sample average intensity gradient and the corresponding site-speci®c intensity gradient.
Quanti®cation of changes in the probe vehicle to skin partition coef®cient For each probe, the concentration difference between the donor and the receiver diffusion cell compartments, DC (see Eqn 2), was approximated by the probe donor concentration C d because C d /C r d 1, where C r is the probe concentration in the receiver compartment. Hence, under these in®nite sink conditions, C d remains a fairly constant quantity in the control and the chemical enhancer permeability studies for both SRB and RBHE.
With a constant C d value for the control and the enhancer solutions for each probe, and given that K = C s | 0/ C d (Schaefer and Redelmeier, 1996) , where K is the probe vehicle to skin partition coef®cient and C s | 0 is de®ned as the probe concentration in the skin at the surface (at z = 0 mm) (Pirot et al, 1997; Deen, 1998) , the probe vehicle to skin partition-coef®cient enhancement, E K , was approximated for each probe by taking the ratio of the average¯uorescence intensity at the skin surface (corresponding to z = 0 mm) for the enhancer and the control samples. Speci®cally,
where I E (z) and I C (z) represent the average intensities of the probe for the enhancer and the control cases, respectively. For these studies, the skin volume associated with the concentration of the probe detected at the skin surface corresponds to the volume de®ned by the area of the ®eld scanned and the two-photon laser beam point size in the axial or zdirection. Because the relative change in the probe vehicle to skin partition coef®cient is the quantity of interest here, for the same skin surface volume, only the average probe surface intensity is considered.
RESULTS
Three-dimensional visualization of¯uorescent probe spatial distributions in the skin To illustrate the qualitative details that one can obtain using the TPM z-scans, representative threedimensional images of the probe spatial concentration (or intensity) distributions for one site of the four sites examined per skin sample are shown in Fig 4(a±d) . Each three-dimensional construct represents a ®eld of 112 Q 112 mm and a depth of 32 mm from the surface of the skin. The color scales used for these images are also shown in Fig 4, where regions in red (corresponding to 300) re¯ect regions of high probe concentration and regions in blue (corresponding to 0) re¯ect regions of low probe concentration. The C in each part of the ®gure points to structures resembling corneocytes. Hydrophobic probe RBHE Figure 4(a,b) illustrates the spatial distributions of the hydrophobic probe RBHE across the thickness of the skin sample (32 mm) without (the control) and with the chemical enhancer oleic acid, respectively. Illustrating that the SC acts as the primary barrier to transdermal transport, the majority of the drop in intensity for RBHE occurs over the uppermost layers of the skin, approximately over 10 mm, limiting the¯uorescence signal detection beyond that depth (see Fig 4a,b) . Hydrophilic probe SRB Figure 4(c,d) illustrates the spatial distributions of the hydrophilic probe SRB across the skin sample (32 mm). For the hydrophilic probe, SRB, in the control condition (see Fig 4c) , the majority of the drop in probe intensity also occurs in the uppermost layers of the skin. In the presence of the oleic acid enhancer, however, the gradual decline of SRB concentration across the SC and into the VE (see Fig 4d) suggests that the chemical enhancer has reduced the SC barrier properties such that the contribution of the VE to the overall skin barrier becomes more noticeable.
Similarities between RBHE and SRB For both RBHE and SRB, the presence of oleic acid is qualitatively observed to increase the quantity of each probe on the surface of the skin (cf . Fig 4a and  Fig 4b for RBHE, and Fig 4c and Fig 4d for SRB) , which is indicative of increased partitioning of the probe into the skin. Moreover, the quantities of RBHE and SRB detected in the control samples are signi®cantly lower as they lie in the blue region of the color scale (see Fig 4a,c) . Increases in both the partition coef®cient and the concentration gradient of the probe due to the presence of oleic acid should contribute to an increase in the overall transdermal transport of the probe, as described by Eqns 1 and 5. Based on these three-dimensional images, regions of high probe concentration surround the corneocytes, suggesting that the primary transport pathway across the skin is through the lipid multilamellar regions between the corneocytes for both the hydrophobic and the hydrophilic model drugs examined. Because the resolution of these two-photon microscope images is limited by the laser scanning spot size of » 1 mm, molecular scale details are not visually accessible. Nevertheless, as discussed above and shown below, changes in the transport microenvironment can be inferred from a quanti®cation of these images. Differences between RBHE and SRB Although both the hydrophobic and the hydrophilic model drugs examined appear to traverse the skin primarily via the intercellular route, the differences observed in the nature of the probe spatial distributions throughout the skin samples suggest that oleic acid enhancer action operates through different mechanisms for these two model drugs. These qualitative differences include the pronounced decrease observed in the average intensity for the hydrophobic probe over the ®rst 8 mm of the skin sample, represented by the changes in the color scale from green to blue and from red to blue (see Fig 4a,b) , for the control and the enhancer samples, respectively. A similar decrease in probe¯uorescence signal, from green to blue (see Fig 4c) , was detected for the hydrophilic probe over the ®rst 16 mm in the control skin sample, but its spatial distribution in the presence of oleic acid enhancer changed, showing the perfusion of hydrophilic probe throughout the 32 mm of the skin sample (see Fig 4d) , highlighted by the regions in red. Insight into these differences in transport mechanisms can be gained from a more quantitative analysis of the two-photon data, which is presented next.
Quanti®cation of the¯uorescent probe spatial distributions in the skin
Figures 5 and 6 show the measured average photon counts vs skin depth, representing the respective average concentration pro®les of the hydrophobic (RBHE) and the hydrophilic (SRB) model drugs as described in the Materials and Methods section. (The estimated instrumentation error in the z direction is 5%.) The average intensity pro®le at the skin surface (z = 0 mm) is proportional to the magnitude of the probe skin± vehicle partition coef®cient, and the slope of the curve corresponds to the probe concentration gradient. Quanti®cation of the relative change in the probe vehicle±skin partition coef®cient, E K The higher probe concentrations detected at the surfaces of the three-dimensional representations of the oleic acid treated samples (see Fig 4b,d ) agree with their corresponding probe intensity pro®les in which 4-fold increases in the average photon counts are measured at z = 0 mm (cf. h and j in Figs 5 and 6) . A calculation of the probe partition-coef®cient enhancement, E K , utilizing the I E and I C values obtained from the SAIP at z = 0 mm, yields values of 4.33 T 3.45 and 4.56 T 2.05 for the hydrophobic and the hydrophilic probes, respectively. The partitioning of both the hydrophobic and the hydrophilic probes from the control solution (1 : 1 PBS/ethanol) into the skin is enhanced to a similar degree in the presence of the oleic acid enhancer. For both probes, the large error in E K arises from the site to site variation of the probe average¯uorescence pro®les, as seen in Figs 5 and 6 , in which the error bars re¯ect the variation in the SSDP detected at each skin depth (z-coordinate). The deduced E K values further substantiate the increased partitioning of both RBHE and SRB from the vehicle to the skin in the presence of the oleic acid chemical enhancer shown in Fig 4b and d, respectively . Quanti®cation of the relative change in the probe intensity gradient, E g In addition to the partition-coef®cient enhancement, the intensity gradients were calculated (see Materials and Methods section) for the SAIP in Figs 5 and 6 , and the results are reported in Table II with respect to the slope and R 2 corresponding to the linear regression. The error corresponding to the slope calculations represents the statistical range in which a 95% con®dence level exists. As expected from the SAIP, the intensity gradients for RBHE and SRB in the control vehicles are similar, with values of ±7.66 T 0.21 counts per mm and ±8.37 T 0.38 counts per mm, respectively; however, the presence of the oleic acid enhancer signi®cantly increases the steepness of the intensity gradient of RBHE (dI/dz = ± 41.16 T 1.67 counts per mm), while having little effect on the SRB intensity gradient (dI/dz = ± 10.42 T 0.58 counts per mm). Based on the slope values determined, the concentration-gradient enhancements are E g = 5.37 T 0.26 for RBHE and E g = 1.24 T 0.09 for SRB, indicating that the RBHE¯ux enhancement results from an increase in the concentration gradient, one of the factors driving permeant¯ux across the skin (see Eqn 1), as well as by increased probe partitioning into the skin. Quanti®cation of site-speci®c probe intensity gradients The average intensity gradients calculated from the SAIP were compared with the intensity gradients obtained from each speci®c site examined by performing a linear regression of the SSDP. The four to six SSDP (not shown) that generate each SAIP revealed variations in probe intensity at each depth that were twice as large as those observed at the corresponding depth of the SAIP. These statistics suggest that the error bars associated with each SAIP may be reduced with increased sampling of different sites on the skin sample. Based on the statistics of a normal distribution, the error associated with each Figure 5 . Sample average intensity pro®les of RBHE. Key: sample average intensity counts calculated at each depth for the control (j) and the enhancer (h) vehicles. The average photon counts is plotted vs the corresponding skin depth. The error bars indicate 1 SD from the sample average intensity of the ®ve and six different sites sampled for each condition, respectively. SAIP should decrease by the square root of the number of SSDP utilized in the analysis. Table III reports the individual site-speci®c probe intensity gradient values followed by the average of those values for each of the SSDP belonging to each of the four cases examined (RBHEcontrol, RBHE-enhancer, SRB-control, and SRB-enhancer). The control and enhancer cases corresponding to RBHE for the SAIP intensity gradient (± 7.66 T 0.21 and ±41.16 T 1.67) and the average of the SSDP intensity gradients (± 7.66 T 3.72 and ±41.17 T 26.65) revealed nearly identical means. Whereas the averages of the SSDP intensity gradients (± 9.65 T 2.58, control; ±15.43 T 4.47, enhancer) calculated for SRB were, in general, more negative in value than the corresponding SAIP intensity gradients (± 8.37 T 0.38, control; ±10.42 T 0.58, enhancer) , the differences between the two intensity gradient calculations are ultimately captured within their error bars. The analysis of the SSDP intensity gradients presented above suggests that the application of the SAIP in the methodology introduced here serves as an average representation of the different SSDP sampled.
A discussion of the changes in the skin barrier diffusion length and the skin diffusion coef®cient of the permeant deduced from the permeability enhancement, E P , concentration-gradient enhancement, E g , and partition-coef®cient enhancement, E K , for RBHE and SRB is presented below.
Quanti®cation of oleic acid-induced changes in transdermal transport properties The enhancements of the concentration gradient, E g , vehicle to skin partition coef®cient, E K , permeability coef®cient, E P , skin barrier diffusion length, E l, and diffusion coef®cient, E D , are shown in Fig 7. The error bars represent 1 SD from the average value, except for E g , for which the error bars indicate a 95% con®dence level in the results (described in Materials and Methods). Factors contributing to the enhanced permeability values for the hydrophilic probe (E P = 9.59 T 2.92) and the hydrophobic probe (E P = 7.35 T 1.00) are immediately revealed by the E g and E K values. The E g values corresponding to the probe concentration gradients increased by 5.37 T 0.26 (gray bar in Fig 7) and 1.24 T 0.09 (striped bar in Fig 7) , for the hydrophobic (RBHE) and the hydrophilic (SRB) probes, respectively. Despite the negligible change in the concentration gradient obtained for SRB in the presence of oleic acid, the value for E K (4.56 T 2.05, striped bar in Fig 7) suggests that the main driving force for¯ux enhancement in this case is due to the SRB increased af®nity for the SC.
As shown in Fig 6 , the average intensity pro®le for SRB maintains a similar shape in both the presence and the absence of oleic acid, but is translated in the direction of increasing intensity by a factor of 4 in the presence of oleic acid. For RBHE, both E g and E K clearly indicate increases in the average concentration gradient and skin partitioning in the presence of oleic acid with values of 5.37 T 0.26 and 4.33 T 3.45 (gray bars in Fig 7) , respectively.
These results presented for both the hydrophilic and the hydrophobic probes are consistent with the two-layer transdermal diffusion model proposed by Yamashita et al (1995) , who used The linear regression for each SSDP was performed for the ®rst 11 axial scans at each site to obtain the intensity gradient, dI/dz. The value of dI/dz for each site is reported for the control (C) and enhancer (E) cases. The R 2 value following each reported dI/dz value describes the accuracy of the linear ®t.
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For each group of SSDP, the average value, AVG, of the intensity gradients calculated for the respective number of sites imaged per skin sample is reported as the mean T SD. Figure 7 . Relative changes in transport parameters. Key: RBHE (gray bars), SRB (striped bars). With the exception of E g , the error bars indicate 1 SD from the mean. The error bars corresponding to E g for both probes represent the upper and the lower limit of a 95% con®dence level. The enhancement factors calculated for RBHE are: E g = 5.37 T 0.26, E K = 4.33 T 3.45, E P = 7.35 T 1.00, E l = 0.81 T 0.64, and E D = 1.37 T 0.20. The enhancement values calculated for SRB are: E g = 1.24 T 0.09, E K = 4.56 T 2.05, E P = 9.59 T 2.92, E l = 3.66 T 1.67, and E D = 7.70 T 2.41. mannitol (polar) and 6-mercaptopurine (nonpolar) as the model drugs in a system that accounts for the existence of both a polar and a nonpolar permeant transport route through the SC. For both routes, their results showed that the oleic acid action increased their model parameter associated with permeant partitioning from the vehicle to the skin (Yamashita et al, 1995) . Quanti®cation of oleic acid-induced changes in the SC microtransport environment as re¯ected in E D and E l The oleic acid-induced changes in the hydrophilic probe microtransport environment that promote increased transdermal diffusion are discussed next. From the relative changes in the intensity gradient, E g , and the skin partition coef®cient, E K , one can subsequently estimate the changes that arise in the permeant skin barrier diffusion length, re¯ected in E l , and in the permeant skin diffusion coef®cient, re¯ected in E D . E l is calculated using Eqn 10, in which the permeant skin barrier diffusion length enhancement is simply the ratio of E K and E g , the two enhancement factors readily obtained using the SAIP shown in Figs 5 and 6. By applying Eqn 6, in which E D can now be obtained as a function of E P , E K , and E l upon rearranging the equation, the quantitative changes in the permeant skin diffusion coef®cient can be obtained.
For the hydrophilic probe, SRB, in the presence of oleic acid, an increase in the skin barrier diffusion length was calculated, as well as clearly visualized in Fig 6 (h) . Based on Eqn 5, an increase in the skin barrier diffusion length would contribute to a decrease in the permeability, but the concomitant increase in probe partition coef®cient, E K = 4.56 T 2.05, and diffusion coef®cient, E D = 7.70 T 2.41, offsets the increase in skin barrier diffusion length, E l = 3.66 T 1.67
In contrast to the changes estimated for the microtransport properties of the hydrophilic probe, the skin barrier diffusion length and diffusion coef®cient of the hydrophobic probe, RBHE, show minor deviations from the control condition in the presence of oleic acid, as re¯ected in the values of E l = 0.81 T 0.64 and E D = 1.37 T 0.20, respectively.
The deduced values for the both the skin barrier diffusion length enhancement and the diffusion-coef®cient enhancement are discussed below, ®rst for the hydrophilic probe, SRB, and subsequently for the hydrophobic probe, RBHE.
DISCUSSION
Implications of changes detected in the hydrophilic probe transport properties The observed increase in the skin barrier diffusion length (E l = 3.66 T 1.67) for the hydrophilic probe in the presence of oleic acid suggests the creation of a microtransport environment in the SC, which is more amenable to hydrophilic drug transport, such that the predominant skin barrier now includes both the SC and the viable epidermis. The precise signi®cance of the 4-fold increase in the skin barrier diffusion length, with respect to the physical dimensions and structural components of the different skin layers, requires further investigation. As revealed by the increase in the diffusion coef®cient (E D = 7.70 T 2.41), the permeant microenvironment has noticeably changed to allow for the increased mobility of SRB. Therefore, the diffusion of the hydrophilic permeant exhibits a greater sensitivity to changes in the lipid environment because of its inherent incompatibility with the SC lipid environment under passive conditions. The increases measured for the vehicle to skin partition coef®cient, the skin barrier diffusion length, and the diffusion coef®cient re¯ect microenvironmental changes in the SC. The relationship between the microenvironmental changes reported here and the microscale descriptions of transport pathway changes noted in the literature, such as, increases in the hydrophilic permeant pathway pore sizes (Yamashita et al, 1995) as well as oleic acid phase separation and domain formation in the SC lipid region (Ongpipattanakul et al, 1991) , requires further investigation.
Implications of changes detected in the hydrophobic probe transport properties Compared with the signi®cant increase detected in the skin barrier diffusion length for the hydrophilic probe, the minor change in this value for the hydrophobic probe (E l = 0.81 T 0.64) indicates that, even in the presence of oleic acid enhancer action, the SC comprises the primary barrier to transdermal transport, as the deeper layers of the skin do not contribute to the transport barrier delineated by the drop in the probe concentration across the ®rst 8 mm of the skin. The minor effect of oleic acid on the microtransport environment of the hydrophobic probe, as re¯ected in the E D value of 1.37 T 0.20, can be attributed to the natural intrinsic compatibility of the hydrophobic probe with the SC lipid environment.
The increase in SC lipid¯uidity associated with oleic acid enhancer action, in this case, is primarily manifested by the increased partitioning of the hydrophobic molecule into the skin, re¯ected in E K = 4.33 T 3.45, followed by the increased concentration gradient driving transdermal diffusion, re¯ected in E g = 5.37 T 0.26. The error bars shown on the SAIP curves re¯ect the heterogeneity of the SC and result from the spread in the individual pixel intensities for each SSDP. We believe that these large variations (twice as large as those observed for the SAIP) in the SSDP are mainly dominated by the skin location morphologic variation on the micron scale. In the presence of oleic acid chemical enhancer action, the variance for both RBHE (Fig 5, h) and SRB (Fig 6, h) , increases, as re¯ected in the increased size of the error bars relative to the control cases (Figs 5 and 6, j). In light of this observation, additional variance may also result from the nonuniform action of the oleic acid. A heterogeneous distribution of oleic acid throughout the SC may result from the formation of separate domains of oleic acid pools within the SC lipids (Ongpipattanakul et al, 1991) .
Based on the data presented, the variance due to SC morphology may be reduced by sampling over larger areas at each site in the skin sample; however, as the sampling area increases, the intrinsic heterogeneity of the skin properties and the nonuniform action of the oleic acid chemical enhancer may become more evident. Further studies over larger skin areas may enable us to address better the site to site variations observed in the skin model. Moreover, the application of an alternative approach, where regions containing no probe (corneocyte regions) are excluded from the average intensity calculation, may provide information pertaining to the probe diffusion and distribution on the submicron scale. By evaluating only the probe-rich regions, this approach eliminates the morphology-dependent contribution to the spread in SSDP variations. Whereas the methodology applied in our studies has examined probe transport through a medium consisting of two different components (corneocytes and lipid multilamellae), the alternative analysis method focuses more speci®cally on transport through the continuous phase of the SC (the lipid regions). Hence, this approach decomposes the SC into its more fundamental components, and evaluates one aspect of the overall mechanism of transdermal transport. Future studies involving the rigorous comparison of results arising from the two data analysis schemes, as well as an increased sampling of skin sites, will provide additional insight into the mechanism of chemical enhancer action.
CONCLUSIONS
The advantages of TPM in providing three-dimensional images detailing the chemical enhancer-induced changes in¯uorescent probe distributions in the upper 32 mm of skin samples, with respect to important structural features such as the corneocytes and the lipid multilamellar region, have been demonstrated here. More importantly, we have presented here, for the ®rst time, a methodology that quantitatively characterizes the signi®cance of the visualized differences in these three-dimensional images with respect to the commonly investigated permeant transport parameters. The agreement between the apparent changes in probe concentration gradient, probe partitioning, probe diffusion coef®-cient, and probe skin barrier diffusion length, estimated using this method, and the phenomenologic explanations of permeability enhancement detailed in the literature illustrates the potential of two-photon microscopy in elucidating the mechanisms of transdermal transport processes at the mechanistic level. The results presented above for this in vitro model system, in addition to the noninvasive nature of TPM, reinforces the potential applicability of utilizing this method in future studies to understand the changes underlying the experimentally measured permeabilities for in vivo systems.
